Skip to main content
Paula Clemens, MD, Neurology, Pittsburgh, PA, UPMC Presbyterian Shadyside

PaulaRuthClemensMD

Neurology Pittsburgh, PA

Associate Professor, Neurology, University of Pittsburgh School of Medicine

Dr. Clemens is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Clemens' full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1988 - 1990
  • Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
    Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Neurology, 1985 - 1988
  • Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
    Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalInternship, Internal Medicine, 1984 - 1985
  • MCP-Hahnemann College of Medicine
    MCP-Hahnemann College of MedicineClass of 1984

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1995 - 2024
  • TX State Medical License
    TX State Medical License 1993 - 1995
  • MN State Medical License
    MN State Medical License 1988 - 1993
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping  
    Paula R Clemens, Vamshi K Rao, Craig M Zaidman, JAMA Neurology

Authored Content

  • Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingMay 2020

Press Mentions

  • ReveraGen and Santhera Announce FDA Orphan Grant Funding for Clinical Trial with Vamorolone in Becker Muscular Dystrophy
    ReveraGen and Santhera Announce FDA Orphan Grant Funding for Clinical Trial with Vamorolone in Becker Muscular DystrophySeptember 27th, 2021
  • Long-Term Viltepso Prevents Motor Function Decline in DMD Boys
    Long-Term Viltepso Prevents Motor Function Decline in DMD BoysJuly 13th, 2021
  • VILTEPSO® (Viltolarsen) Injection: Long-Term Efficacy and Safety Data Presented at the PPMD 2021 Virtual Annual Conference
    VILTEPSO® (Viltolarsen) Injection: Long-Term Efficacy and Safety Data Presented at the PPMD 2021 Virtual Annual ConferenceJuly 1st, 2021
  • Join now to see all

Grant Support

  • Network Of Excellence In Neuroscience Clinical Trials (Univ Of Pittsburgh Crs)National Institute Of Neurological Disorders And Stroke2011
  • Becker Muscular Dystrophy: A Natural History Study To Predict Efficacy Of EXON SKNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
  • Genetic Rescue Of Dystrophic Muscle In UteroNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2008
  • Genetic Rescue Of Dystrophic Mucle In UteroNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2006
  • Core--Training ProgramNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003
  • Analysis And Modulation Of Immunity In Gene TherapyNational Institute Of Allergy And Infectious Diseases1999–2003
  • Longterm Rescue Of Muscle Function By Dystrophin Delivery--Adenoviral VectorsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2002
  • Core--Mouse BreedingNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2002
  • Gene Therapy For Duchenne Muscular DystrophyNational Institute Of Neurological Disorders And Stroke1996–2000
  • Gene Therapy For Duchenne Muscular DystrophyNational Institute Of Neurological Disorders And Stroke1993–1995

Hospital Affiliations